Intratumor Heterogeneity in Evolutionary Models of Tumor Progression
暂无分享,去创建一个
Franziska Michor | Kevin Leder | Rick Durrett | Jasmine Foo | R. Durrett | J. Mayberry | F. Michor | K. Leder | J. Foo | John Mayberry
[1] R. Durrett. Probability: Theory and Examples , 1993 .
[2] S. Resnick. Extreme Values, Regular Variation, and Point Processes , 1987 .
[3] H. Ohtsuki,et al. Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.
[4] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[5] R. Durrett,et al. Evolutionary dynamics of tumor progression with random fitness values. , 2010, Theoretical population biology.
[6] Martin A. Nowak,et al. Genetic Progression and the Waiting Time to Cancer , 2007, PLoS Comput. Biol..
[7] Goldie Jh,et al. Role of mathematical modeling in protocol formulation in cancer chemotherapy. , 1985 .
[8] Paul Loya. Dirichlet and Fresnel Integrals via Iterated Integration , 2005 .
[9] N. Komarova,et al. Stochastic modeling of drug resistance in cancer. , 2006, Journal of theoretical biology.
[10] Rafael Sanjuán,et al. The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Dick,et al. Stem cell concepts renew cancer research. , 2008, Blood.
[12] Yoh Iwasa,et al. The Evolution of Two Mutations During Clonal Expansion , 2007, Genetics.
[13] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[14] M. S. Ridout,et al. Generating random numbers from a distribution specified by its Laplace transform , 2009, Stat. Comput..
[15] S. Wolman. Cytogenetic heterogeneity: its role in tumor evolution. , 1986, Cancer genetics and cytogenetics.
[16] Hansjörg Albrecher,et al. Asymptotic analysis of a measure of variation , 2007 .
[17] G. Nicolson. Generation of phenotypic diversity and progression in metastatic tumor cells , 2004, Cancer and Metastasis Reviews.
[18] John D Pfeifer,et al. Tumor Heterogeneity Affects the Precision of Microarray Analysis , 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[19] Kornelia Polyak,et al. Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution? , 2007, Cell cycle.
[20] Carissa A. Sanchez,et al. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array‐CGH , 2007, Genes, chromosomes & cancer.
[21] Richard Durrett,et al. Evolution of Resistance and Progression to Disease during Clonal Expansion of Cancer , 2009 .
[22] Lars Egevad,et al. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer , 2005, Scandinavian journal of urology and nephrology.
[23] R. Lenski,et al. Dynamics of adaptation and diversification: a 10,000-generation experiment with bacterial populations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] Martin T. Ferris,et al. Beneficial Fitness Effects Are Not Exponential for Two Viruses , 2008, Journal of Molecular Evolution.
[25] R. Lenski,et al. The fate of competing beneficial mutations in an asexual population , 2004, Genetica.
[26] Jason Schweinsberg,et al. The waiting time for m mutations , 2008, 0802.3485.
[27] Carissa A. Sanchez,et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.
[28] J. Krug,et al. Clonal interference in large populations , 2007, Proceedings of the National Academy of Sciences.
[29] R. Lenski,et al. Long-Term Experimental Evolution in Escherichia coli. I. Adaptation and Divergence During 2,000 Generations , 1991, The American Naturalist.
[30] Q. Shao. Self-normalized large deviations , 1997 .
[31] W. Thilly,et al. A statistical model to estimate variance in long term-low dose mutation assays: testing of the model in a human lymphoblastoid mutation assay. , 1989, Mutation research.
[32] M. Foley,et al. Quinoline antimalarials: mechanisms of action and resistance. , 1997, International journal for parasitology.
[33] A. Morley,et al. Mutation rate of normal and malignant human lymphocytes. , 1987, Cancer research.
[34] J. Krug,et al. The Speed of Evolution in Large Asexual Populations , 2009, 0910.0219.
[35] R Rosen,et al. "Role of mathematical modeling in protocol formulation in cancer chemotherapy". , 1986, Cancer treatment reports.
[36] M Imhof,et al. Fitness effects of advantageous mutations in evolving Escherichia coli populations. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[37] B. Sevin,et al. Evidence of tumor heterogeneity in cervical cancers and lymph node metastases as determined by flow cytometry , 1993, Cancer.
[38] Jozef L. Teugels,et al. Expectation of the Ratio of the Sum of Squares to the Square of the Sum: Exact and Asymptotic Results , 2002 .
[39] Rick Durrett,et al. Traveling waves of selective sweeps , 2009, 0910.5730.
[40] J H Goldie,et al. A stochastic model for the origin and treatment of tumors containing drug-resistant cells. , 1986, Bulletin of mathematical biology.
[41] G. Heppner,et al. Mutagenic activity of tumor-associated macrophages in Salmonella typhimurium strains TA98 and TA 100. , 1984, Cancer research.
[42] G. Heppner. Tumor heterogeneity. , 1984, Cancer research.
[43] Lei Si Ni Ke Resnick.S.I.. Extreme values. regular variation. and point processes , 2011 .
[44] S Torquato,et al. Emergence of a Subpopulation in a Computational Model of Tumor Growth , 2022 .
[45] S. Bhunya,et al. Cytogenetic effects of fenvalerate in mammalian in vivo test system. , 1989, Mutation research.
[46] C. Mallows,et al. Limit Distributions of Self-normalized Sums , 1973 .
[47] T. Kunkel. DNA Replication Fidelity* , 2004, Journal of Biological Chemistry.
[48] K. Ito,et al. Stochastic models for subpopulation emergence in heterogeneous tumors. , 1989, Bulletin of mathematical biology.
[49] I. Fidler,et al. Biological diversity in metastatic neoplasms: origins and implications. , 1982, Science.
[50] I. Fidler,et al. Tumor heterogeneity and the biology of cancer invasion and metastasis. , 1978, Cancer research.